VERAXA Biotech Showcases Cancer Platforms at BIO Convention
June 22, 2026 — VERAXA Biotech (NASDAQ: VRXA) presents new data on BiTAC-ADC and BiTAC-TCE platforms at BIO International Convention, aiming for precision cancer therapy with reduced toxicity.